Narnolia

Narnolia

Toll Free No: 1800-103-7212

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE3256.50-20.35 (-0.62 %)
PREV CLOSE ( ) 3276.85
OPEN PRICE ( ) 3285.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16014
TODAY'S LOW / HIGH ( )3245.00 3363.00
52 WK LOW / HIGH ( )2352 3363
NSE3255.30-22.85 (-0.7 %)
PREV CLOSE( ) 3278.15
OPEN PRICE ( ) 3289.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3255.30 (431)
VOLUME 924466
TODAY'S LOW / HIGH( ) 3240.05 3364.95
52 WK LOW / HIGH ( )2351.2 3364.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
22Feb Dr. Reddys Laboratories informs about
Further to intimations dated August 20, 2019 and February 16, 2020 with..
19Feb Dr. Reddys Laboratories informs about
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Di..
17Feb Bharti Airtel, Granules India and Dr.
Bharti Airtel and Nokia, a global telecommunications equipment and servi..
17Feb USFDA completes audit at Dr. Reddy's L
US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy..
17Feb Dr. Reddys inches up as USFDA complete
Dr. Reddys Laboratories is currently trading at Rs. 3321.00, up by 13.50..
Financials
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit521712773
Gross Profit 6175 17007
Operating Profit 825025381
Net Sales 30440106255
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
peergroup  7322.90 (2.05%)
M.Cap ( in Cr)16865.09
Ajanta Pharma (BSE)
peergroup  1446.05 (10.03%)
M.Cap ( in Cr)12618.42
Ipca Laboratories (BSE)
peergroup  1456.15 (3.43%)
M.Cap ( in Cr)18398.76
Solara Active Pharma (BSE)
peergroup  680.25 (6.01%)
M.Cap ( in Cr)1772.41
Alkem Laboratories (BSE)
peergroup  2657.75 (1.39%)
M.Cap ( in Cr)31777.39
Shareholding Pattern
MUTUAL FUNDS/UTI 9.29%
FI/BANKS/INSURANCE 5.71%
PROMOTERS 26.76%
NON-INSTITUTION 13.8%
GOVERNMENT 0%
FII 0%
About Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 3256.5. Its current market capitalisation stands at Rs 54111.03 Cr. In the latest quarter, company has reported Gross Sales of Rs. 154482 Cr and Total Income of Rs.157857 Cr. The company's management includes Allan Oberman, Shikha Sharma, Leo Puri, Sridar Iyengar, Prasad R Menon, Kalpana Morparia, Bruce L A Carter, Bharat N Doshi, GV Prasad, K Satish Reddy.

It is listed on the BSE with a BSE Code of 500124 , NSE with an NSE Symbol of DRREDDY and ISIN of INE089A01023. It's Registered office is at 8-2-337,Road No. 3,Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are A Rama Chandra Rao & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, SR Batliboi & Associates LLP

Directory

current IPO
  • --
upcoming IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room